LPL Financial LLC

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1403438 FORT MILL, SC

Position in ARQT

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$2,914,353

+$101,737 QoQ

Shares Held

111,150

-6.9% QoQ

Ownership

0.088%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#96

of 271 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 1% Shared 0% None 99%

Healthcare · as of Jun 30, 2026

LPL Financial LLC holds $557,763,742 across 203 Biotechnology names. ARQT ranks #31 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	289,111	$143,610,107
2	REGN	Regeneron Pharmaceuticals, Inc.	65,755	$41,000,872
3	ARWR	Arrowhead Pharmaceuticals, Inc.	310,761	$25,330,129
4	ARGX	Argenx SE	19,499	$18,090,587
5	ALNY	Alnylam Pharmaceuticals, Inc.	57,890	$17,426,626
6	HALO	Halozyme Therapeutics, Inc.	203,557	$15,932,406
7	RPRX	Royalty Pharma plc	249,117	$13,967,990
8	INSM	INSMED Inc	128,553	$13,706,320

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,914,353	111,150	-6.9%	Shares	Sole	2026-08-07
2026-03-31	$2,812,616	119,381	+6.7%	Shares	Sole	2026-05-06
2025-12-31	$3,248,820	111,874	-4.3%	Shares	Sole	2026-02-11
2025-09-30	$2,204,017	116,924	-3.9%	Shares	Sole	2025-11-12
2025-06-30	$1,705,070	121,617	+5.1%	Shares	Sole	2025-08-12
2025-03-31	$1,810,439	115,757	-4.2%	Shares	Sole	2025-05-07
2024-12-31	$1,684,025	120,892	-4.3%	Shares	Sole	2025-02-11
2024-09-30	$1,174,404	126,280	-15.6%	Shares	Sole	2024-11-08
2024-06-30	$1,390,722	149,540	-5.5%	Shares	Sole	2024-08-07
2024-03-31	$1,567,811	158,205	-16.6%	Shares	Sole	2024-05-10
2023-12-31	$612,546	189,643	+127.1%	Shares	Sole	2024-02-14
2023-09-30	$443,454	83,513	+141.5%	Shares	Sole	2023-11-13
2023-06-30	$329,566	34,582	—	Shares	Sole	2023-07-31
No filing history on record for this holder in this stock.